Sex differences in micro- and macro-vascular complications of diabetes mellitus
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Vascular complications are a leading cause of morbidity and mortality in both men and women with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus, however the prevalence, progression and pathophysiology of both microvascular (nephropathy, neuropathy and retinopathy) and macrovascular [coronary heart disease (CHD), myocardial infarction, peripheral arterial disease (PAD) and stroke] disease are different in the two sexes. In general, men appear to be at a higher risk for diabetic microvascular complications, while the consequences of macrovascular complications may be greater in women. Interestingly, in the absence of diabetes, women have a far lower risk of either micro- or macro-vascular disease compared with men for much of their lifespan. Thus, the presence of diabetes confers greater risk for vascular complications in women compared with men and some of the potential reasons, including contribution of sex hormones and sex-specific risk factors are discussed in this review. There is a growing body of evidence that sex hormones play an important role in the regulation of cardiovascular function. While estrogens are generally considered to be cardioprotective and androgens detrimental to cardiovascular health, recent findings challenge these assumptions and demonstrate diversity and complexity of sex hormone action on target tissues, especially in the setting of diabetes. While some progress has been made toward understanding the underlying mechanisms of sex differences in the pathophysiology of diabetic vascular complications, many questions and controversies remain. Future research leading to understanding of these mechanisms may contribute to personalized- and sex-specific treatment for diabetic micro- and macro-vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the case of diabetes, micro-vascular alterations secondary to hyperglycemia, which are more prevalent in women, 54”
From Defining risk factors associated with difficult peripheral venous Cannulation: A systematic review and meta-analysis (2020) · cites this paper as [54]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Research works printed but not linked: 2
- Brand, 1989, Diabetes, intermittent claudication, and risk of cardiovascular events, The Framingham Study. Diabetes, 38, 504
- Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study, A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med., 138, 1
Cited by
Sex differences in metabolic regulation and diabetes susceptibility
Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J.-F., Montagner, A., & Gourdy, P. (2020) · Diabetologia · doi:10.1007/s00125-019-05040-3 · Cited by 923
Risk Factors for Young-Onset Dementia in the UK Biobank
Hendriks, S., Ranson, J. M., Peetoom, K. K. B., Lourida, I., Tai, X. Y., de Vugt, M. E., Llewellyn, D. J., & Köhler, S. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.4929 · Cited by 174
Obesity and cardiovascular disease in women
Manrique‐Acevedo, C., Chinnakotla, B., Padilla, J., Martinez‐Lemus, L. A., & Gozal, D. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0548-0 · Cited by 173
Machine Learning and Smart Devices for Diabetes Management: Systematic Review
Makroum, M. A., Adda, M., Bouzouane, A., & Ibrahim, H. (2022) · Sensors · doi:10.3390/s22051843 · Cited by 145
“Among the microvascular complications are nephropathy, neuropathy, and retinopathy, whereas those of the macrovascular type are coronary heart disease (CHD), myocardial infarction, peripheral arterial disease (PAD), and stroke [9].”
BackgroundDiabetic Retinopathy Screening: A Systematic Review on Patients’ Non-Attendance
Kashim, R., Newton, P., & Ojo, O. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010157 · Cited by 128
“Some studies estimate a DR prevalence of 34.6% [6,7] and find that it is more common in T1DM as compared to T2DM [7].”
BackgroundInfluentialPlatania, C. B. M., Maisto, R., Trotta, M. C., D’Amico, M., Rossi, S., Gesualdo, C., D’Amico, G., Baltă, C., Herman, H., Hermenean, A. O., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14665 · Cited by 135
Wang, W., Ji, Q., Ran, X., Li, C., Kuang, H., Yu, X., Fang, H., Yang, J., Liu, J., Xue, Y., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3702 · Cited by 135
“34 Moreover, sex differences also affect the onset of diabetic neuropathy since males developed neuropathic complications at 63 years, approximately 4 years earlier than females (at 67 years).”
BackgroundGeng, K., Ma, X., Jiang, Z., Gu, J., Huang, W., Wang, W., Xu, Y., & Xu, Y. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09748-8 · Cited by 118
“Recent studies demonstrated that diabetes affect many organs, including the eye, kidney, heart, and brain (Aambo and Klemsdal 2017; Hill 2014; Maric-Bilkan 2017).”
BackgroundEffects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases
Zhou, Y., Zhang, H., & Peng, C. Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771793 · Cited by 104
“Major microvasculature defects evident in diabetes include diabetic retinopathy, diabetic kidney disease and diabetic neuropathy (Maric-Bilkan, 2017; Yang et al., 2017).”
BackgroundVascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies
Naderi‐Meshkin, H., Cornelius, V. A., Eleftheriadou, M., Potel, K. N., Setyaningsih, W. A. W., & Margariti, A. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03521-2 · Cited by 108
“While strides have been taken in understanding sex-specific mechanisms in diabetic vascular issues [61], many questions persist, and evidence for sex disparities in microvascular disease is limited.”
BackgroundSIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
Meng, T., Qin, W., & Liu, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568861 · Cited by 108
Cross Talks between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy
Kowluru, R. A. (2023) · Cells · doi:10.3390/cells12020300 · Cited by 112
Diabetic Vasculopathy: Macro and Microvascular Injury
Mota, R. I., Morgan, S. E., & Bahnson, E. M. (2020) · Current Pathobiology Reports · doi:10.1007/s40139-020-00205-x · Cited by 92
Epigenetic modifications in diabetes
Kowluru, R. A., & Mohammad, G. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154920 · Cited by 97
Rodríguez-Calero, M. A., Blanco-Mavillard, I., Morales-Asencio, J. M., Fernández-Fernández, I., Castro-Sánchez, E., & de Pedro-Gómez, J. E. (2020) · Heart & Lung · doi:10.1016/j.hrtlng.2020.01.009 · Cited by 78
Piani, F., Melena, I. L., Tommerdahl, K. L., Nokoff, N., Nelson, R. G., Pavkov, M. E., van Raalte, D. H., Cherney, D. Z. I., Johnson, R. J., Nadeau, K. J., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107841 · Cited by 82
Sex Differences in Diabetic Kidney Disease
Maric‐Bilkan, C. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.08.026 · Cited by 84
“Other general factors that lead to DKD in a sex-specific manner include: type and duration of diabetes, biological age, age at onset of diabetes, and genetic and epigenetic factors, et cetera.(67,68) Classical risk factors for DKD, including glycemic control, hypertension, obesity, and dyslipidemia have also been repo…”
BackgroundSelf-citationWolde, H. F., Atsedeweyen, A., Zeleke, A. J., Awoke, T., Sisay, M. M., Tsegaye, A. T., & Alemu, S. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0280-0 · Cited by 72
Chase-Vilchez, A., Chan, I. H. Y., Peters, S. A. E., & Woodward, M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01130-4 · Cited by 66
“Understanding the interplay between sex, diabetes, and PAD-onset is particularly important given the women with intermittent claudication and diabetes have greater excess risk of coronary heart disease, stroke, and heart failure than men with these same co-morbidities [18].”
BackgroundGenes associated with Type 2 Diabetes and vascular complications
Montesanto, A., Bonfigli, A. R., Crocco, P., Garagnani, P., Luca, M. D., Boemi, M., Marasco, E., Pirazzini, C., Giuliani, C., Franceschi, C., et al. (2018) · Aging · doi:10.18632/aging.101375 · Cited by 64
Novel Model Predicts Diabetic Nephropathy in Type 2 Diabetes
Jiang, S., Fang, J., Yu, T., Liu, L., Zou, G., Gao, H., Zhuo, L., & Li, W. (2020) · American Journal of Nephrology · doi:10.1159/000505145 · Cited by 59
The role of gender disparities in kidney injury
Harris, R. C., & Zhang, M. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.23 · Cited by 60
“At the time of entry, the average eGFR was 43.9 mL/min per 1.73 mm2 in women and 45.7 in men, with equivalent distributions of CKD stages between the sexes.”
ResultInfluentialDiabetes pathogenesis and management: the endothelium comes of age
Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 57
“Moreover, it has also been proposed that androgens are detrimental in part because nondiabetic men have a higher prevalence of CVD than premenopausal women (Maric-Bilkan, 2017).”
BackgroundStrutz, J., Cvitic, S., Hackl, H., Kashofer, K., Appel, H. M., Thüringer, A., Desoyé, G., Koolwijk, P., & Hiden, U. (2018) · Clinical Science · doi:10.1042/cs20180825 · Cited by 54
Hay, M., Barnes, C. A., Huentelman, M. J., Brinton, R. D., & Ryan, L. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01090-w · Cited by 55
Chen, J., Li, C., Bu, C. L. N., Wang, Y., Qi, M., Fu, P., & Zeng, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003143 · Cited by 52
“[29] Despite the research focusing on disparities in sex in the NCDs has advanced in recent years, we strongly suggest further exploration of potential mechanisms for sex variations in NCDs caused by renal dysfunction, which will allow the identification of sex-specific modifications in medical…”
Abot, A., Fried, S. G., Cani, P. D., & Knauf, C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0100 · Cited by 53
“Color images are available online. metabolic tissue (adipose tissue, liver, and muscles) (33), LPS is associated with microvascular (neuropathy, retinopathy) and macrovascular (peripheral arterial disease [PAD], stroke, myocardial infarction) complications observed during advanced T2D (139).”
Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication
Steiger, S., Li, L., Bruchfeld, A. N., Stevens, K., Moran, S. M., Floege, J., Caravaca‐Fontán, F., Mirioğlu, Ş., Teng, O. Y. K., Frangou, E. A., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.08.038 · Cited by 49
“187 190 In contrast, one meta-analysis evaluating the effect of angiotensin-converting enzyme inhibitors in 11 randomized studies observed a faster CKD progression in women than in men after correcting for blood pressure and proteinuria.”
Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study
Lu, J., Liu, X., Jiang, S., Kan, S., An, Y., Zheng, C.-X., Li, X., Liu, Z., & Xie, G. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac057 · Cited by 47
The Role of the EGF Receptor in Sex Differences in Kidney Injury
Zhang, M., Sasaki, K., Yan, L., Li, Z., Pan, Y., Jin, G.-N., Wang, Y., Niu, A., Wang, S., Fan, X., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018121244 · Cited by 42
Yang, G., Yeung, S. L. A., & Schooling, C. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104259 · Cited by 48
on behalf of the PREDICTOR Study Group, Cesaroni, G., Mureddu, G. F., Agabiti, N., Mayer, F., Stafoggia, M., Forastiere, F., Latini, R., Masson, S., Davoli, M., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10442-3 · Cited by 42
Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
Capobianco, E. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0155-4 · Cited by 39
“…build effectively actionable clinical decision support systems (CDSS) from predictive modelling and patient-driven analytics? from heart and cerebrovascular diseases, and microvascular complications manifested as nephropathy, neuropathy and retinopathy are known to occur at various ages [29, 30].”
BackgroundAssociations between circulating inflammatory markers, diabetes type and complications in youth
Aulich, J., Cho, Y. H., Januszewski, A. S., Craig, M. E., Selvadurai, H. C., Wiegand, S., Jenkins, A. J., & Donaghue, K. C. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12913 · Cited by 39
Bansal, S., Canziani, M. E. F., Birne, R., Anker, S. D., Bakris, G. L., Filippatos, G. S., Rossing, P. R., Ruilope, L. M., Farjat, A. E., Kolkhof, P., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-076444 · Cited by 40
Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real
Merz, C. N. B., Ramineni, T., & Leong, D. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000543 · Cited by 39
The Risk Factors for Diabetic Retinopathy in a Chinese Population: A Cross-Sectional Study
Sun, Q., Jing, Y., Zhang, B., Gu, T., Meng, R., Sun, J., Zhu, D., & Wang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5340453 · Cited by 38
“There is a growing body of evidence indicating that multiplicity and complexity of sex hormone action target organs, particularly in the diabetic setting [8].”
Wang, S., Du, S., Lv, Y., Wang, W., & Zhang, F. (2020) · IUBMB Life · doi:10.1002/iub.2267 · Cited by 35
“6% of patients with diabetes.(2) The pathogenesis of DR is multifactor: modifiable factors such as blood glucose, blood pressure, serum lipids, and smoking; non-modifiable risk factors are duration, age, genetic predisposition, and ethnicity; others including pregnancy, microaneurysm, and any DR in the second eye.”
BackgroundDiané, A., Al-Shukri, N. A., Mu-u-min, R., & Al-Siddiqi, H. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03327-5 · Cited by 38
Pterostilbene Prevents Early Diabetic Retinopathy Alterations in a Rabbit Experimental Model
Millán, I., Desco, C., Torres-Cuevas, I., Pérez, S., Pulido, I., Mena, S., Mataix, J., Asensi, M. A., & Ortega, Á. (2019) · Nutrients · doi:10.3390/nu12010082 · Cited by 34
“This global increase in diabetes prevalence is associated directly with hyperglycaemia alterations, which are a potent risk factor in macro- and microvascular alterations [2].”
BackgroundKorpole, N. R., Kurada, P., & Korpole, M. R. (2022) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_28_22 · Cited by 45
“Recent reviews found that in majority, there was an insignificant gender difference in regards to diabetic retinopathy while some reported a higher predisposition for males.[1,40,41] In addition, a recent Japanese study has reported that women with type 2 diabetes mellitus have a higher predisposition for advanced dia…”
Li, J., Chattopadhyay, K., Xu, M., Chen, Y., Hu, F., Chu, J., & Li, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235161 · Cited by 36
“However, the presence of T2DM confers a greater risk for vascular complications in women, and some of the potential reasons include the contribution of sex hormones and sex-specific risk factors [37].”
BackgroundSex differences and risk factors for diabetes mellitus - an international study from 193 countries
Elling, D. L., Surkan, P. J., Enayati, S., & El‐Khatib, Z. (2018) · Globalization and Health · doi:10.1186/s12992-018-0437-7 · Cited by 35
Sexual Dimorphism in Obesity-Associated Endothelial ENaC Activity and Stiffening in Mice
Padilla, J., Woodford, M. L., Lastra‐González, G., Martinez-Diaz, V., Fujie, S. J., Yang, Y., Lising, A. M. C., Ramirez‐Perez, F. I., Aroor, A. R., Morales‐Quinones, M., et al. (2019) · Endocrinology · doi:10.1210/en.2019-00483 · Cited by 31
RetractedLeo, M. D., Peixoto‐Neves, D., Yin, W., Raghavan, S., Muralidharan, P., Mata‐Daboin, A., & Jaggar, J. H. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00690.2020 · Cited by 38
Sex differences in type 2 diabetes: an opportunity for personalized medicine
Johnson, M. L., Preston, J. D., Rashid, C. S., Pearson, K. J., & Ham, J. N. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00571-2 · Cited by 35
“In general, men tend to suffer more from peripheral arterial and microvascular complications of diabetes, whereas women tend toward thromboembolic and macrovascular complications [11, 12].”
BackgroundKazama, S., Kazama, J. J., & Ando, N. (2019) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.2019-01 · Cited by 27
Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019
Quigley, M., Morton, J. I., Lazzarini, P. A., Zoungas, S., Shaw, J. E., & Magliano, D. J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110189 · Cited by 26
Campesi, I., Seghieri, G., & Franconi, F. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.06.007 · Cited by 25
Sex-Related Aspects in Diabetic Kidney Disease—An Update
Loeffler, I., & Ziller, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082834 · Cited by 27
Seghieri, G., Policardo, L., Gualdani, E., Anichini, R., & Francesconi, P. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01292-y · Cited by 24
Chen, J. H. C., Johnson, D. W., Wong, G., Boudville, N. C., Borlace, M., Walker, R., Hawley, C. M., McDonald, S. P., & Lim, W. H. (2020) · Peritoneal Dialysis International · doi:10.1177/0896860820918708 · Cited by 23
“These sex differences may be attributed to the effects of sex hormones on vascular endothelium and myocardium, genetic influences on lipid and insulin biology and behavioural dissimilarity for cardiovascular risk factors and access to healthcare.(9,12) However, the potential effects of sex differences and the risk of…”
BackgroundProximal tubular epithelial insulin receptor mediates high-fat diet–induced kidney injury
Lee, H. J., Mariappan, M. M., Norton, L., Bakewell, T. M., Féliers, D., Oh, S. B., Donati, A., Rubannelsonkumar, C. S., Venkatachalam, M. A., Harris, S. E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143619 · Cited by 21
Bilen, A., Çalık, İ., Yayla, M., Dinçer, B., Tavacı, T., Çınar, İ., Bilen, H., Çadırcı, E., Halıcı, Z., & Mercantepe, F. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.216 · Cited by 21
Yang, J., & Jiang, S. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s363474 · Cited by 22
“Overall, men seem to be at a higher risk for microvascular complications in diabetes, while the consequences of diabetic macrovascular complications may be greater in women.(28) Because there was male predominance in the present study (62%), and this may cause some bias, the confirmation of the results should be neede…”
ResultUnderstanding the sex disparity in living kidney donation
Prasad, G. V. R. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13015 · Cited by 21
Diané, A., Mohammed, L. I., & Al-Siddiqi, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01171-8 · Cited by 23
“, coronary heart disease, myocardial infarction) complications associated with both uncontrolled T1D and T2D are immensely costly and difficult to manage, representing a major medical and financial challenge for many countries [5, 6].”
BackgroundMicrovascular Skeletal-Muscle Crosstalk in Health and Disease
Pepe, G. J., & Albrecht, E. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310425 · Cited by 21
Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control
Khedr, D., Hafez, M., Lumpuy‐Castillo, J., Emam, S. M., AbdelMassih, A. F., El‐Mougy, F., Elkaffas, R. H., Mahíllo, I., Lorenzo, Ó., & Musa, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145079 · Cited by 54
Frisbee, J. C., Lewis, M. T., Kasper, J. D., Chantler, P. D., & Wiseman, R. W. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00751.2018 · Cited by 18
Wang, G., Hu, X., Zhao, H., Li, H.-L., Chu, S.-F., & Liu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1132036 · Cited by 18
“(40) concluded that age-related differences in hormone levels, glycemic control, duration of diabetes, and ethnic background could explain the reported gender differences in DR risk.”
BackgroundHuo, W., Li, H., Zhang, Y., & Li, H. (2019) · The FASEB Journal · doi:10.1096/fj.201902086r · Cited by 17
Chiu, Y.-W., Wu, C., Chen, P., Wei, Y., Hsu, L., & Wang, S. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.016 · Cited by 19
Zureik, A., Julla, J., Erginay, A., Vidal-Trécan, T., Juddoo, V., Gautier, J., Massin, P., Tadayoni, R., Riveline, J., & Couturier, A. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-021-05298-7 · Cited by 17
“The underlying mechanisms and the role of estrogens and androgens in retinal diseases have been recently investigated [30].”
BackgroundBeck, L., Su, J., Comerma-Steffensen, S., Pinilla, E., Carlsson, R., Hernanz, R., Sheykhzade, M., Danielsen, C. C., & Simonsen, U. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00667 · Cited by 18
“Moreover, diabetic men appear at a higher risk for diabetic microvascular complications, while the consequences of macrovascular complications may be greater in women (Maric-Bilkan, 2017).”
BackgroundResultMu-u-min, R., Diané, A., Allouch, A., & Al-Siddiqi, H. (2023) · Biomedicines · doi:10.3390/biomedicines11061577 · Cited by 17
Akpalu, J., Yawson, A. E., Osei‐Poku, F., Atiase, Y., Yorke, E., Adjei, P., Nkromah, K., & Akpalu, A. K. (2018) · Stroke Research and Treatment · doi:10.1155/2018/7521351 · Cited by 17
Haq, Z., Yang, D., Psaras, C., & Stewart, J. M. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.3.12 · Cited by 15
Comparison of Pulmonary and Systemic NO‐ and PGI2‐Dependent Endothelial Function in Diabetic Mice
Fedorowicz, A., Buczek, E., Mateuszuk, Ł., Czarnowska, E., Sitek, B., Jasztal, A., Chmura-Skirliñska, A., Dib, M., Steven, S., Daiber, A., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4036709 · Cited by 15
“Furthermore, although peripheral endothelial dysfunction represents a well-recognized hallmark of peripheral diabetic macro- and microangiopathies [2, 7, 15], the evidence on the development of pulmonary endothelial dysfunction in diabetes is rather conflicting.”
BackgroundFemale Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity
Lee, H. J., Min, L., Gao, J., Matta, S., Drel, V. R., Saliba, A., Tamayo, I. M., Montellano, R., Hejazi, L., Maity, S., et al. (2024) · Diabetes · doi:10.2337/db23-0807 · Cited by 15
Molecular Mechanisms of Adenosine Stress T1 Mapping
Shah, S. A., Reagan, C. E., French, B. A., & Epstein, F. H. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011774 · Cited by 14
Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats
Spires, D. R., Palygin, O., Levchenko, V., Isaeva, E., Klemens, C. A., Khedr, S., Nikolaienko, O., Kriegel, A. J., Cheng, X., Yeo, J., et al. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00009.2021 · Cited by 16
“Some studies have found that women with diabetes die at higher rates from diabetes-related comorbidities, including DKD and cardiovascular complications (8, 9).”
BackgroundPan, Q., Fei, S., Zhang, L., Chen, H., Luo, J., Wang, W., Xiao, F., & Guo, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1164536 · Cited by 16
“Moreover, a review by Maric-Bilkan (30) showed that the prevalence of DPN in T2DM was 46.2% in Caucasian women and 52.6% in Caucasian men; the prevalence of DPN in T2DM is higher in women than in men in Asian populations.”
BackgroundInfluentialNeuraminidase inhibition improves endothelial function in diabetic mice
Foote, C. A., Ramirez‐Perez, F. I., Smith, J. A. H., Ghiarone, T., Morales‐Quinones, M., McMillan, N. J., Augenreich, M. A., Power, G. J., Burr, K., Aroor, A. R., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00337.2023 · Cited by 16
Ríos‐Silva, M., Santos-Álvarez, R., Trujillo, X., Cárdenas, Y., López, M., Bricio‐Barrios, J. A., Leal, C. A., Saavedra‐Molina, A., Huerta-Trujillo, M., Espinoza-Mejía, K. E., et al. (2018) · Molecules · doi:10.3390/molecules24010036 · Cited by 14
“Additionally, the sexes have shown different predispositions to developing kidney injury due to diabetes [37].”
BackgroundVascular Diseases in Women: Do Women Suffer from Them Differently?
Farkas, K., Stanek, A., Zbinden, S., Borea, B., Ciurica, S., Moore, V., Maguire, P., Abola, M. T. B., Alajar, E. B., Marcoccia, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041108 · Cited by 13
“Although scarce and inconclusive, some evidence suggest that men might be at a higher risk for diabetic microvascular complications [168].”
BackgroundMoldovan, R. A., Hidalgo, M. R., Castañé, H., Jiménez-Franco, A., Joven, J., Burks, D. J., Galán, A., & Garcia‐García, F. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156241 · Cited by 15
Lee, C., Hsing, S.-C., Lin, Y.-T., Lin, C. S., Chen, J., Chen, Y., & Fang, W. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189768 · Cited by 11
Sex-Related Effects of Gut Microbiota in Metabolic Syndrome-Related Diabetic Retinopathy
García‐Llorca, A., & Kararigas, G. (2023) · Microorganisms · doi:10.3390/microorganisms11020447 · Cited by 11
Ho, L.-J., Sheu, W. H., Lo, S.-H., Yeh, Y., Hwu, C., Huang, C., Hsieh, C., & Kuo, F.-C. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01018-9 · Cited by 12
“In fact, vascular diseases are the leading causes of morbidity and mortality in patients with diabetes [3].”
BackgroundSaucedo, L., Pfister, I. B., Schild, C., & Garweg, J. G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293139 · Cited by 11
Why We Need Sex-Gender Medicine: The Striking Example of Type 2 Diabetes
Seghieri, G., Franconi, F., & Campesi, I. (2022) · Diabetology · doi:10.3390/diabetology3030034 · Cited by 11
Strain and sex-based glucocentric & behavioral differences between KK/HlJ and C57BL/6J mice
Inglis, A. L., Shibin, S., Ubungen, R., Farooq, S., Mata, P., Thiam, J., Al-Mohanna, F. A., & Collison, K. S. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112646 · Cited by 10
Markousis‐Mavrogenis, G., Bacopoulou, F., Kolovou, G. D., Pons, M.-R., Giannakopoulou, A., Papavasiliou, A., Kitas, G. D., Chrousos, G. P., & Mavrogeni, S. I. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11506 · Cited by 13
Fan, Z., Guo, C., Zhang, Y., Yao, J., Liao, L., & Dong, J. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s220719 · Cited by 10
“angiopathies (DA), particularly atherosclerosis (AS), are the leading causes of disability and mortality in this large cohort of patients.(2) Although the mechanisms”
BackgroundZhang, T., Li, T., & Jin, P. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2472039 · Cited by 11
“Behaviorally, men tend to have higher levels of risk factors such as smoking, obesity, hypertension, and elevated blood sugar [29,30].”
Non-communicable disease (NCD) burden and their contributing factors among women
Malik, Z. I., & Ahmad, A. M. R. (2025) · Health Care For Women International · doi:10.1080/07399332.2025.2472174 · Cited by 11
“Type 2 diabetes has been seen to reduce ovarian hormones while increasing testosterone hormones in women, which is then subsequently associated with increased coronary heart disease risk (Maric-Bilkan, 2017).”
Li, S., Li, N., Li, L., Wang, Y., Liu, Y., Wang, Y., & Zhan, J. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s403483 · Cited by 9
“other hand, gender differences in diabetic vascular complications have been recognized.(11) However, research to date has not yet investigated the gender differences in the relationship between TBIL and diabetic vascular complications in Chinese people with type 2 diabetes mellitus (T2DM).”
BackgroundZhou, Z., Huang, Y., Zhuang, X., Guo, Y., Xie, P., Xiong, Z., Liu, M., Zhang, W., Zhong, J., Li, Y., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.034626 · Cited by 11
“43 It has also been re-ported that differences in renal function may contribute to the differences in outcome, but this study did not find any differences in renal function.”
Słomiński, B., Skrzypkowska, M. W., Ryba-Stanisławowska, M. E., & Brandt, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12670 · Cited by 9
Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes
Waluś‐Miarka, M., Trojak, A., Miarka, P., Kapusta, M., Kawalec, E., Idzior−Waluś, B., & Malecki, M. T. (2019) · Innate Immunity · doi:10.1177/1753425919891628 · Cited by 9
“However, understanding the underlying mechanisms of sex differences in the pathophysiology of diabetic vascular complications raises many controversies.(3,24,25) Furthermore, data on inflammation biomarkers and sex in patients with diabetes are scarce.”
BackgroundLi, C., Yu, H., Zhu, Z., Shang, X., Huang, Y., Sabanayagam, C., Yang, X., & Liu, L. (2023) · Journal of Global Health · doi:10.7189/jogh.13.04027 · Cited by 9
Diabetes mellitus tipo 2: Latinoamérica y Colombia, análisis del último quinquenio
Ruiza, L. X. A., Merchán, M. A., & Vargas, L. O. (2024) · Revista Med · doi:10.18359/rmed.6067 · Cited by 8
Wan, R., Zhou, J., Mao, R., Zheng, Y., Zhou, F., Pan, L., Hong, Y., Jin, L., Li, S., & Zhu, C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167437 · Cited by 8
Diabetic Endothelial Cell Glycogen Synthase Kinase 3β Activation Induces VCAM1 Ectodomain Shedding
Brishti, M. A., Raghavan, S., Lamar, K., Singh, U. P., Collier, D. M., & Leo, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814105 · Cited by 9
Gender Difference in the Risk of Adverse Outcomes After Diabetic Foot Disease: A Mini-Review
Seghieri, G., Bellis, A. D., Seghieri, M., Gualdani, E., Policardo, L., Franconi, F., & Francesconi, P. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200716195600 · Cited by 9
Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome
Díez‐Villanueva, P., García‐Acuña, J. M., Raposeiras‐Roubín, S., Barrabés, J. A., Cordero, A., Martínez‐Sellés, M., Bardajı́, A., Marín, F. R., Ruiz-Nodar, J. M., Vicente‐Ibarra, N., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194403 · Cited by 8
Owei, I., UMEKWE, N. A., Mohamed, H., Ebenibo, S., Wan, J. Y., & Dagogo-Jack, S. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00094 · Cited by 8
López‐de‐Andrés, A., Jiménez‐García, R., Hernández‐Barrera, V., Jiménez‐Trujillo, I., Zamorano‐León, J. J., Carabantes-Alarcón, D., López‐Herránz, M., de Miguel-Yanes, J. M., & de Miguel‐Díez, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073659 · Cited by 8
“From a pathophysiological point of view sex-differences in cerebrovascular complication among T2DM subjects include biological factors like genetic predisposition, sex hormones, and neuro–humoral pathways, as well as psychosocial, behavioral, and environmental factors [38–40].”
Toward Sex-Specific Biomaterials Innovation: A Perspective
Koons, G. L. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00342 · Cited by 7
Metadata
- Authors
- Maric-Bilkan, C.
- Affiliations
- Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2017-04-19
- Volume
- 131
- Issue
- 9
- Pages
- 833-846
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2605955340
- Cited by
- 217
- References
- 144
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 20 · 2023: 29 · 2022: 20 · 2021: 35 · 2020: 41 · 2019: 17 · 2018: 19 · 2017: 2
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- sex differences, diabetes mellitus, diabetic microvascular complications, diabetic macrovascular complications, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, coronary artery disease, myocardial infarction, peripheral arterial disease, stroke, sex hormones, estrogen, androgens, sex-specific risk factors, sex-specific treatment
- MeSH terms
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Male, Risk Factors, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.